Crossmark

Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy

Crossref DOI link: https://doi.org/10.1186/s13019-020-01140-z

Published Online: 2020-05-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiménez-Rivera, Juan José https://orcid.org/0000-0002-7491-7343
Álvarez-Castillo, Andrea https://orcid.org/0000-0003-4063-9370
Ferrer-Rodríguez, Jorge https://orcid.org/0000-0003-2502-7720
Iribarren-Sarrías, José Luis https://orcid.org/0000-0003-2753-7484
García-González, Martín Jesús https://orcid.org/0000-0002-9674-2513
Jorge-Pérez, Pablo https://orcid.org/0000-0002-5411-3700
Lacalzada-Almeida, Juan https://orcid.org/0000-0002-9863-3222
Pérez-Hernández, Rosalía https://orcid.org/0000-0002-4913-1365
Montoto-López, Javier https://orcid.org/0000-0002-8226-7467
Martínez-Sanz, Rafael https://orcid.org/0000-0002-2426-3783
License Information

Text and Data Mining valid from 2020-05-24

Version of Record valid from 2020-05-24
More Information

Article History

Received: 20 January 2020

Accepted: 4 May 2020

First Online: 24 May 2020

Ethics approval and consent to participate

: This study was approved by the institutional ethical committee of Hospital Universitario de Canarias. All patients signed the informed consent for surgery. The sequential assignment patients signed the study consent form. The ethical committee advised that the study consent was not necessary in the historical cohort.

: All patients signed the informed consent for surgery that includes consent for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below